Nature profiles College of Medicine neuroscience doctoral student Christin Godale
Christin Godale, a doctoral student in the Neuroscience Graduate Program, was recently featured in an article in Nature highlighting her advocacy work for neuroscience funding.
Godale was diagnosed at age 2 with epilepsy, which led to her interest in neuroscience. She works with the Society for Neuroscience and has met with federal policymakers and elected officials to increase funding for research.
“Like many people with epilepsy, I rely on anti-seizure medications, which allow me to pursue my dreams and ambitions. Advocating for basic science is very personal for the epilepsy community and myself. Researchers should consider the voices of patient advocates when performing basic research, writing a grant application or giving a scientific presentation,” she says in the article.
Godale works in the laboratory of Steve Danzer, PhD, associate professor in the Department of Anesthesiology, at Cincinnati Children’s.
Last year Godale was selected as an award recipient of the National Institutes of Health (NIH) Outstanding Scholars in Neuroscience Award Program, which recognizes early-career scientists who are conducting exceptional research and who have great academic potential in their scientific training. She also has received an NIH Predoctoral Fellowship from the National Institute of Neurological Disorders and a Predoctoral Fellowship from the American Epilepsy Society.
UC College of Medicine graduate student Christin Godale. (Photo courtesy of Cincinnati Children's)
Featured image at top: Christin Godale/Colleen Kelley/UC Creative + Brand.
Tags
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.